Paola M. Bertazzoni
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Clinical and Biological Implications of TP53 Abnormalities in Relapsed/Refractory Multiple Myeloma: The DEDALO Study.
Journal: Clinical lymphoma, myeloma & leukemia
Published: April 27, 2026
Targeting CD38 to reduce anti-HLA antibody levels: A new and effective option to be integrated into desensitization protocols?
Journal: Transplant immunology
Published: June 13, 2025
Anti-CD38 monoclonal antibody impairs CD34+ mobilization and affects clonogenic potential in multiple myeloma patients.
Journal: Blood transfusion = Trasfusione del sangue
Published: September 29, 2023
Plasma cell-directed therapy and anti-HLA antibody production: A successful combination?
Journal: Current research in translational medicine
Published: March 30, 2023
Prospective evaluation of minimal residual disease in the phase II FORTE trial: a head-to-head comparison between multiparameter flow cytometry and next-generation sequencing.
Journal: EClinicalMedicine
Published: February 15, 2023
Primary cardiac lymphoma with isolated parenchymal central nervous system relapse: report of two cases and review of the literature.
Journal: Ecancermedicalscience
Published: June 29, 2014
Pyogenic vertebral osteomyelitis complicating abdominal penetrating injury: case report and review of the literature.
Journal: World journal of emergency surgery : WJES
Published: November 05, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026